JW (Cayman) Therapeutics Co. Ltd

JWCTFOTCHealthcare● Active

$0.36

+$0.12(+49.52%)

Market Cap$147889562

P/E Ratio—

52W High$0.6602

52W Low$0.2375

Avg Volume6K

Open$0.34

Beta1.91

Overview

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Revenue

Annual & quarterly revenue history · segment & region breakdown

JWCTF · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

JW (Cayman) Therapeutics Co. Ltd trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY —

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

281 employees

—

5Y CAGR

—

Fiscal year end

Dec 31

Currency

USD · GAAP

Filing

10-K / 10-Q

Source: FMP · JW (Cayman) Therapeutics Co. Ltd SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

– · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth

JWCTF revenue by year · JWCTF revenue history · JWCTF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income JW (Cayman) Therapeutics Co. Ltd receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

JW (Cayman) Therapeutics Co. Ltd reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from JW (Cayman) Therapeutics Co. Ltd's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

JWCTF revenue · 4 questions

JWCTF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

JWCTF revenueJWCTF annual revenuewhat is JWCTF revenueJWCTF TTM revenue

▸ Source: FMP · JW (Cayman) Therapeutics Co. Ltd SEC filings · GAAP · JW (Cayman) Therapeutics Co. Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026